JPRN-UMIN000053613招募中Unknown
Prognostic Predictors for the efficacy of Immune Checkpoint Inhibitors - Prognostic Predictors for the efficacy of Immune Checkpoint Inhibitors
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients deemed inappropriate for the study by the principal investigator or co-investigators.
研究者
相似试验
招募中
不适用
To identify the predictors for good, intermediate and poor treatment outcome in cardiac sarcoidosis.CTRI/2018/05/013646CARE HOSPITALS
尚未招募
不适用
Treatment effect and prediction survival of Immune checkpoint inhibitors by FDG-PET/CT: A multicenter studyJPRN-UMIN000047230Hyogo College of Medicine100
进行中（未招募）
1 期
Comparison of the immunogenicity and safety of a combined adsorbed low dose diphtheria, tetanus and inactivated poliomyelitis vaccine (REVAXIS®) with a combined diphtheria, tetanus and inactivated poliomyelitis vaccine (DT Polio®) when given as a booster dose at 6 years of age - REVAXIS® versus DT Polio® as a second booster in 6 year-old childreot applicable - Healthy volunteers - 6 year-old childEUCTR2005-001446-16-FRSanofi Pasteur MSD760
招募中
不适用
Immune cell score and therapeutic response to checkpoint inhibitors in patients with advanced lung cancerC34Malignant neoplasm of bronchus and lungDRKS00028745niversitätsmedizin Göttingen700
招募中
不适用
Prediction of immune related adverse events by genetic analysismalignant melanoma, lung cancer, renal cancer, Hodgkin lymphomaJPRN-UMIN000026047Yokohama City University Hospital300